Group One Trading, L.P. Galectin Therapeutics Inc Transaction History

Group One Trading, L.P.

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$1.6 - $2.44 $867 - $1,322	542 New	542 $1,000
Q2 2021 Aug 10, 2021	SELL	$2.07 - $5.1 $6,160 - $15,177	-2,976 Closed	0 $0
Q1 2021 May 12, 2021	SELL	$1.96 - $2.57 $9,800 - $12,850	-5,000 Reduced 62.69%	2,976 $6,000
Q4 2020 Feb 10, 2021	BUY	$2.24 - $2.87 $17,866 - $22,891	7,976 New	7,976 $18,000
Q3 2020 Nov 12, 2020	SELL	$2.53 - $3.64 $12,204 - $17,559	-4,824 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$1.66 - $3.15 $107 - $204	65 Added 1.37%	4,824 $15,000
Q1 2020 May 13, 2020	BUY	$1.51 - $3.0 $7,186 - $14,277	4,759 New	4,759 $9,000
Q4 2019 Feb 10, 2020	SELL	$2.79 - $4.32 $2,215 - $3,430	-794 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$3.0 - $4.05 $44,304 - $59,810	-14,768 Reduced 94.9%	794 $3,000
Q2 2019 Aug 09, 2019	BUY	$3.61 - $5.0 $56,178 - $77,810	15,562 New	15,562 $65,000
Q1 2019 May 13, 2019	SELL	$3.86 - $6.02 $19,164 - $29,889	-4,965 Closed	0 $0
Q4 2018 Feb 06, 2019	SELL	$3.43 - $5.74 $144,060 - $241,080	-42,000 Reduced 89.43%	4,965 $17,000
Q3 2018 Nov 08, 2018	SELL	$3.68 - $6.93 $226,415 - $426,375	-61,526 Reduced 56.71%	46,965 $282,000
Q2 2018 Aug 14, 2018	BUY	$3.16 - $9.16 $326,551 - $946,585	103,339 Added 2005.8%	108,491 $690,000
Q1 2018 May 11, 2018	BUY	$3.78 - $5.97 $19,474 - $30,757	5,152 New	5,152 $24,000
Q4 2017 Feb 09, 2018	SELL	$1.54 - $3.34 $35,500 - $76,993	-23,052 Closed	0 $0
Q3 2017 Nov 15, 2017	BUY	$1.67 - $2.3 $38,496 - $53,019	23,052	23,052 $49,000

9.65M

1.16M

1.98M

Ticker GALT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,426,000
Market Cap $123M
Description
Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.